No article text was recorded for this version.
preclinical model fidelity
Version 1 of 133 papers39 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women
- Blog: Immunoproteomic Analysis of Human Serological Antibody Responses to Vaccination with Whole-Cell Pertussis Vaccine (WCV)
- Blog: Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study
- Blog: Establishment of a Hyperacute Rejection Model of ABO-Incompatible Renal Transplantation in Nonhuman Primates
- Blog: Multiomics profiling reveals the benefits of gamma-delta (γδ) T lymphocytes for improving the tumor microenvironment, immunotherapy efficacy and prognosis in cervical cancer
- Blog: GITRL on inflammatory antigen presenting cells in the lung parenchyma provides signal 4 for T-cell accumulation and tissue-resident memory T-cell formation
- Blog: Oncolytic activity of a coxsackievirus B3 strain in patient-derived cervical squamous cell carcinoma organoids and synergistic effect with paclitaxel
- Blog: Perfluorocarbon nanodrug induced oxygen self-enriching sonodynamic therapy improves cancer immunotherapy after insufficient radiofrequency ablation
- Blog: Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model
- Blog: TLR4-MyD88/Mal-NF-kB Axis Is Involved in Infection of HSV-2 in Human Cervical Epithelial Cells
- Blog: Advances in the Application of Preclinical Models in Photodynamic Therapy for Tumor: A Narrative Review
- Blog: Immunization with Adenoviral Vectors Carrying Recombinant IL-12 and E7 Enhanced the Antitumor Immunity against Human Papillomavirus 16-associated Tumor
- Blog: Dendritic Cell Mediated Delivery of Plasmid DNA Encoding LAMP/HIV-1 Gag Fusion Immunogen Enhances T Cell Epitope Responses in HLA DR4 Transgenic Mice
- Blog: Autologous humanized PDX modeling for immuno-oncology recapitulates features of the human tumor microenvironment
- Blog: Downregulation of complement factor H attenuates the stemness of MDA‑MB‑231 breast cancer cells via modulation of the ERK and p38 signaling pathways
- Blog: Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine Efficacy
- Blog: MAIVeSS: streamlined selection of antigenically matched, high-yield viruses for seasonal influenza vaccine production
- Blog: Rapid synthesis of a Bi@ZIF-8 composite nanomaterial as a near-infrared-II (NIR-II) photothermal agent for the low-temperature photothermal therapy of hepatocellular carcinoma
- Blog: Inhibition of CDC25B With WG-391D Impedes the Tumorigenesis of Ovarian Cancer
- Blog: Safety and Comparability of Controlled Human Plasmodium falciparum Infection by Mosquito Bite in Malaria-Naïve Subjects at a New Facility for Sporozoite Challenge
- Blog: Engineered virus-hunter vaccine overcomes HBV immune tolerance
- Blog: Combination of C-X-C motif chemokine 9 and C-X-C motif chemokine 10 antibodies with FTY720 prolongs the survival of cardiac retransplantation allografts in a mouse model
- Blog: Targeted tumor cell-intrinsic CTRP6 biomimetic codelivery synergistically amplifies ferroptosis and immune activation to boost anti-PD-L1 immunotherapy efficacy in lung cancer
- Blog: Transmission risk evaluation of transfusion blood containing low-density Babesia microti
- Blog: Preclinical Experimental Models for Human Glioma
- Blog: The zebrafish as a novel model for the <i>in vivo</i> study of <i>Toxoplasma gondii</i> replication and interaction with macrophages
- Blog: Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs
- Blog: Intersection of ferroptosis and nanomaterials brings benefits to breast cancer
- Blog: Enzymatically responsive nanocarriers targeting PD-1 and TGF-β pathways reverse immunotherapeutic resistance and elicit robust therapeutic efficacy
- Blog: Discovery of a novel small molecule as CD47/SIRPα and PD-1/PD-L1 dual inhibitor for cancer immunotherapy
- Blog: Proteomics and Organoid Culture Reveal the Underlying Pathogenesis of Hashimoto’s Thyroiditis
- Blog: 1388 CRB-601, an integrin αvβ8 blocking antibody entering phase I: pre-clinical and translational biomarkers for indication selection
- Blog: Detailed analysis of antibody responses to SARS-CoV-2 vaccination and infection in macaques
History & citation
Current · Permanent link
- Overcoming the Translational Gap in Preclinical Immunotherapy merged into this direction (59% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_preclinical_model_fidelity_3069fe1a,
title = {preclinical model fidelity},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/preclinical-model-fidelity/rdr_3069fe1a57114cad9fa4271c8081a40d},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 1, frozen text):
@misc{lacuna_preclinical_model_fidelity_3069fe1a_v1,
title = {preclinical model fidelity},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/preclinical-model-fidelity/rdr_3069fe1a57114cad9fa4271c8081a40d/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}